Miriam Orcutt

Dr. Miriam Orcutt

Institute of Global Health, University College London, London WC1E 6BT, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in The Lancet
Verified
Journal Article
Closed access
MOMiriam Orcutt
Miriam Orcutt
PPParth Patel
Parth Patel
RBRachel Burns
Rachel Burns
LHLucinda Hiam
Lucinda Hiam
RARob Aldridge
Rob Aldridge
IAIbrahim Abubakar
Ibrahim Abubakar

1 July 2021 in eClinicalMedicine
Verified
Journal Article
Open access
EKElias Kondilis
Elias Kondilis
DPDimitris Papamichail
Dimitris Papamichail
SMSophie McCann
Sophie McCann
ECElspeth Carruthers
Elspeth Carruthers
AVApostolos Veizis
Apostolos Veizis
SHSally Hargreaves
Sally Hargreaves
Migrants globally, including refugees and asylum seekers, have experienced adverse clinical and socioeconomic impacts of the COVID-19 pandemic. For approximately 56,000 refugees and asylum seekers in Reception and Identification Centers (RICs) and Reception Sites (RS) in Greece, living in severely substandard living conditions, prevention measures have been impossible with limited provision in terms of routine testing, surveillance, and access to healthcare. These migrant populations have experienced prolonged lockdowns and restricted movement since the pandemic began. We aimed to assess the impact of COVID-19 on refugees and asylum seekers in reception facilities in Greece and explore implications for policy and practice. A retrospective analysis of policy documents and national surveillance data was conducted to identify COVID-19 outbreaks and estimate incidence among asylum seekers and refugees residing in these camps during the first 9 months of the epidemic in Greece (26th February – 15th November 2020). Incidence proportion (IP) of COVID-19 confirmed cases was calculated for three population groups (refugees and asylum seekers in RICs, refugees and asylum seekers in RSs, and the general population in Greece) during three time periods (first wave, second wave, and overall across the 9-month period). Twenty-five COVID-19 outbreaks were identified in refugee and asylum seeker reception facilities, with 6 (85.7%) of 7 RICs and 18 (56.3%) of 32 RSs reporting at least one outbreak during the study period. The overall 9-month COVID-19 IP among refugee and asylum seeker populations residing in RSs on the Greek mainland was 1758 cases per 100,000 population; in RICs the incidence was 2052 cases per 100,000 population. Compared to the general population the risk of COVID-19 infection among refugees and asylum seekers in reception facilities was 2.5 to 3 times higher (p-value<0.001). The risk of acquiring COVID-19 infection was higher among refugee and asylum seeker populations in RSs on the Greek mainland (IP ratio: 2.45; 95% CI: 2.25–2.68) but higher still among refugee and asylum seeker populations in RICs in the Greek islands and the land border with Turkey (IP ratio: 2.86; 95% CI: 2.64–3.10), where living conditions are particularly poor. We identified high levels of COVID-19 transmission among refugees and asylum seekers in reception facilities in Greece. The risk of COVID-19 infection among these enclosed population groups has been significantly higher than the general population of Greece, and risk increases as living conditions deteriorate. These data have immediate implications for policy and practice. Strategies are now needed to ensure refugee and asylum seeker populations are included in national response plans to reduce transmission in at-risk groups for COVID-19, alongside inclusion in plans for COVID-19 vaccine roll out.

1 February 2020 in The Lancet
Verified
Journal Article
Closed access
MOMiriam Orcutt
Miriam Orcutt
PSPaul Spiegel
Paul Spiegel
BKBernadette Kumar
Bernadette Kumar
IAIbrahim Abubakar
Ibrahim Abubakar
JCJocalyn Clark
Jocalyn Clark
LMLancet Migration
Lancet Migration

1 September 2019 in Health Policy
Verified
Journal Article
Closed access
MGM. Gunst
M. Gunst
KJK. Jarman
K. Jarman
VYV. Yarwood
V. Yarwood
SRS. Rokadiya
S. Rokadiya
LCL. Capsaskis
L. Capsaskis
AAAula Abbara
Aula Abbara

1 July 2019 in The Lancet
Verified
Journal Article
Closed access
MOMiriam Orcutt
Miriam Orcutt
DRDiana Rayes
Diana Rayes
ATAhmad Tarakji
Ahmad Tarakji
MKMohamad Katoub
Mohamad Katoub
PSPaul Spiegel
Paul Spiegel
AAAula Abbara
Aula Abbara

26 March 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MKMichael Knipper
Michael Knipper
ASAna Cristina Sedas
Ana Cristina Sedas
SKSalmaan Keshavjee
Salmaan Keshavjee
AAAula Abbara
Aula Abbara
NANaser Almhawish
Naser Almhawish
MOMiriam Orcutt
Miriam Orcutt
Disruption of health services due to the COVID-19 pandemic threatens to derail progress being made in tuberculosis control efforts. Forcibly displaced people and migrant populations face particular vulnerabilities as a result of the COVID-19 pandemic, which leaves them at further risk of developing TB. They inhabit environments where measures such as "physical distancing" are impossible to realize and where facilities like camps and informal temporary settlements can easily become sites of rapid disease transmission. In this viewpoint we utilize three case studies-from Peru, South Africa, and Syria-to illustrate the lived experience of forced migration and mobile populations, and the impact of COVID-19 on TB among these populations. We discuss the dual pandemics of TB and COVID-19 in the context of migration through a syndemic lens, to systematically address the upstream social, economic, structural and political factors that - in often deleterious dynamics - foster increased vulnerabilities and risk. Addressing TB, COVID-19 and migration from a syndemic perspective, not only draws systematic attention to comorbidity and the relevance of social and structural context, but also helps to find solutions: the true reality of syndemic interactions can only be fully understood by considering a particular population and bio- social context, and ensuring that they receive the comprehensive care that they need. It also provides avenues for strengthening and expanding the existing infrastructure for TB care to tackle both COVID-19 and TB in migrants and refugees in an integrated and synergistic manner.